| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 92.832 | 67.711 | 23.465 | 7.248 | 4.535 | 2.321 | 4.031 | 7.842 | 2.781 | 3.544 |
| Total Income - EUR | 96.485 | 73.635 | 23.484 | 7.308 | 4.553 | 2.329 | 4.088 | 8.011 | 2.848 | 3.562 |
| Total Expenses - EUR | 94.066 | 72.152 | 24.407 | 9.297 | 4.105 | 389 | 437 | 3.266 | 554 | 566 |
| Gross Profit/Loss - EUR | 2.419 | 1.483 | -923 | -1.988 | 448 | 1.940 | 3.651 | 4.745 | 2.294 | 2.996 |
| Net Profit/Loss - EUR | 2.419 | 195 | -1.627 | -2.061 | 375 | 1.876 | 3.532 | 4.545 | 1.946 | 2.526 |
| Employees | 2 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Rayuela Intermed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 56 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 76.546 | 54.714 | 25.323 | 21.740 | 21.560 | 22.018 | 23.766 | 23.542 | 17.868 | 3.684 |
| Inventories | 65.978 | 20.348 | 16.195 | 15.897 | 15.590 | 15.273 | 14.935 | 12.276 | 12.714 | 0 |
| Receivables | 10.330 | 34.360 | 8.044 | 5.803 | 5.853 | 5.814 | 5.017 | 4.812 | 4.402 | 1.609 |
| Cash | 238 | 6 | 1.084 | 40 | 118 | 931 | 3.814 | 6.454 | 751 | 2.075 |
| Shareholders Funds | 103 | 342 | -1.291 | -3.328 | -2.857 | -905 | 1.919 | 6.469 | 924 | 1.834 |
| Social Capital | 90 | 134 | 131 | 129 | 158 | 155 | 152 | 152 | 152 | 151 |
| Debts | 76.499 | 54.372 | 26.613 | 25.078 | 24.441 | 22.943 | 21.847 | 17.073 | 16.944 | 1.849 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4616 - 4616" | |||||||||
| CAEN Financial Year |
4616
|
|||||||||
Comments - Rayuela Intermed S.r.l.